0 651

Cited 21 times in

Uterine Artery Embolization for Adenomyosis: Percentage of Necrosis Predicts Midterm Clinical Recurrence

DC Field Value Language
dc.contributor.author김경민-
dc.contributor.author김만득-
dc.contributor.author박성일-
dc.contributor.author배소희-
dc.contributor.author원종윤-
dc.contributor.author이도연-
dc.contributor.author이신재-
dc.date.accessioned2018-03-26T16:41:22Z-
dc.date.available2018-03-26T16:41:22Z-
dc.date.issued2015-
dc.identifier.issn1051-0443-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/156717-
dc.description.abstractPURPOSE: To evaluate the effect of degree of necrosis after uterine artery embolization (UAE) on symptom recurrence at midterm clinical follow-up in patients with adenomyosis. MATERIALS AND METHODS: Women (N = 50) who underwent UAE for symptomatic adenomyosis were retrospectively analyzed. All patients underwent contrast-enhanced magnetic resonance (MR) imaging at baseline and 3 months after UAE and were followed clinically for at least 18 months. The type of adenomyosis was classified as focal or diffuse. The uterine volume and the percentage of necrosis after embolization were measured three-dimensionally on MR imaging. The percentage of the necrosis cutoff point for predicting recurrence was estimated. Patients were divided into 2 groups according to the cutoff point. The rate of recurrence was compared between groups, and risk factors for recurrence were identified. RESULTS: During the follow-up period (range, 18-48 mo), symptom recurrence occurred in 12 of 50 patients. A necrosis cutoff point of 34.3% was calculated to predict recurrence (area under the curve = 0.721; 95% confidence interval [CI] = 0.577-0.839; P = .004). Patients with < 34.3% necrosis (group A, n = 12) were at a significantly higher risk of recurrence than patients with > 34.3% necrosis (group B, n = 38; hazard ratio = 7.0; 95% CI = 2.2, 22.4; P = .001). Initial uterine volume and type of adenomyosis were not associated with recurrence. CONCLUSIONS: The percentage of necrosis in patients with adenomyosis after UAE may predict symptom recurrence at midterm follow-up. The cutoff percentage of necrosis required to predict symptom recurrence was 34.3% in this study.-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherSociety of Cardiovascular and Interventional Radiology-
dc.relation.isPartOfJOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAdenomyosis/diagnosis-
dc.subject.MESHAdenomyosis/epidemiology*-
dc.subject.MESHAdenomyosis/therapy*-
dc.subject.MESHAdult-
dc.subject.MESHComorbidity-
dc.subject.MESHFemale-
dc.subject.MESHFollow-Up Studies-
dc.subject.MESHHumans-
dc.subject.MESHMenorrhagia/diagnosis-
dc.subject.MESHMenorrhagia/epidemiology*-
dc.subject.MESHMiddle Aged-
dc.subject.MESHNecrosis-
dc.subject.MESHPostoperative Complications/diagnosis-
dc.subject.MESHPostoperative Complications/epidemiology*-
dc.subject.MESHPrevalence-
dc.subject.MESHRecurrence-
dc.subject.MESHRepublic of Korea/epidemiology-
dc.subject.MESHRetrospective Studies-
dc.subject.MESHRisk Factors-
dc.subject.MESHSymptom Assessment-
dc.subject.MESHTreatment Outcome-
dc.subject.MESHUterine Artery Embolization/statistics & numerical data*-
dc.subject.MESHUterus/pathology*-
dc.titleUterine Artery Embolization for Adenomyosis: Percentage of Necrosis Predicts Midterm Clinical Recurrence-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine-
dc.contributor.departmentDept. of Radiology-
dc.contributor.googleauthorSohi H.Bae-
dc.contributor.googleauthorMan Deuk Kim-
dc.contributor.googleauthorGyoung Min Kim-
dc.contributor.googleauthorShin Jae Lee-
dc.contributor.googleauthorSung Il Park-
dc.contributor.googleauthorJong Yun Won-
dc.contributor.googleauthorDo Yun Lee-
dc.identifier.doi10.1016/j.jvir.2015.04.026-
dc.contributor.localIdA00296-
dc.contributor.localIdA00420-
dc.contributor.localIdA01510-
dc.contributor.localIdA04752-
dc.contributor.localIdA02443-
dc.contributor.localIdA02718-
dc.contributor.localIdA02944-
dc.relation.journalcodeJ01922-
dc.identifier.eissn1535-7732-
dc.identifier.pmid26074028-
dc.identifier.urlhttp://www.sciencedirect.com/science/article/pii/S1051044315004376-
dc.contributor.alternativeNameKim, Gyoung Min-
dc.contributor.alternativeNameKim, Man Deuk-
dc.contributor.alternativeNamePark, Sung Il-
dc.contributor.alternativeNameBae, Sohi-
dc.contributor.alternativeNameWon, Jong Yun-
dc.contributor.alternativeNameLee, Do Yun-
dc.contributor.alternativeNameLee, Shin Jae-
dc.contributor.affiliatedAuthorKim, Gyoung Min-
dc.contributor.affiliatedAuthorKim, Man Deuk-
dc.contributor.affiliatedAuthorPark, Sung Il-
dc.contributor.affiliatedAuthorBae, Sohi-
dc.contributor.affiliatedAuthorWon, Jong Yun-
dc.contributor.affiliatedAuthorLee, Do Yun-
dc.contributor.affiliatedAuthorLee, Shin Jae-
dc.citation.volume26-
dc.citation.number9-
dc.citation.startPage1290-
dc.citation.endPage1296-
dc.identifier.bibliographicCitationJOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, Vol.26(9) : 1290-1296, 2015-
dc.identifier.rimsid39847-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Radiology (영상의학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.